Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Intensive lactation among women with recent gestational diabetes significantly alters the early postpartum circulating lipid profile: the SWIFT study

Open access

Abstract

Background: Women with a history of gestational diabetes mellitus (GDM) have a 7-fold higher risk of developing type 2 diabetes (T2D). It is estimated that 20-50% of women with GDM history will progress to T2D within 10 years after delivery. Intensive lactation could be negatively associated with this risk, but the mechanisms behind a protective effect remain unknown. Methods: In this study, we utilized a prospective GDM cohort of 1010 women without T2D at 6-9 weeks postpartum (study baseline) and tested for T2D onset up to 8 years post-baseline (n=980). Targeted metabolic profiling was performed on fasting plasma samples collected at both baseline and follow-up (1-2 years post-baseline) during research exams in a subset of 350 women (216 intensive breastfeeding, IBF vs. 134 intensive formula feeding or mixed feeding, IFF/Mixed). The relationship between lactation intensity and circulating metabolites at both baseline and follow-up were evaluated to discover underlying metabolic responses of lactation and to explore the link between these metabolites and T2D risk. Results: We observed that lactation intensity was strongly associated with decreased glycerolipids (TAGs/DAGs) and increased phospholipids/sphingolipids at baseline. This lipid profile suggested decreased lipogenesis caused by a shift away from the glycerolipid metabolism pathway towards the phospholipid/sphingolipid metabolism pathway as a component of the mechanism underlying the benefits of lactation. Longitudinal analysis demonstrated that this favorable lipid profile was transient and diminished at 1-2 years postpartum, coinciding with the cessation of lactation. Importantly, when stratifying these 350 women by future T2D status during the follow-up (171 future T2D vs. 179 no T2D), we discovered that lactation induced robust lipid changes only in women who did not develop incident T2D. Subsequently, we identified a cluster of metabolites that strongly associated with future T2D risk from which we developed a predictive metabolic signature with a discriminating power (AUC) of 0.78, superior to common clinical variables (i.e., fasting glucose, AUC 0.56 or 2-h glucose, AUC 0.62). Conclusions: In this study, we show that intensive lactation significantly alters the circulating lipid profile at early postpartum and that women who do not respond metabolically to lactation are more likely to develop T2D. We also discovered a 10-analyte metabolic signature capable of predicting future onset of T2D in IBF women. Our findings provide novel insight into how lactation affects maternal metabolism and its link to future diabetes onset. Trial registration: ClinicalTrials.gov NCT01967030 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-021-02095-1

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Overview of the study of women, infant feeding, and type 2 diabetes (SWIFT) cohort and study design. The SWIFT cohort is a prospective longitudinal research cohort of 1035 women with recent GDM enrolled at 6–9 weeks postpartum (baseline) from 2008 to 2011. There were 1010 out of 1035 women who were free of diabetes confirmed by a 2-h 75-g OGTT at baseline. Women were followed up annually via 2-h 75-g OGTT up to 2 years postpartum (n = 959 women), and their electronic medical records (EHR) were utilized to obtain additional clinical diagnoses of diabetes from baseline to 8 years post-baseline (till January 16, 2019). Fasting plasma samples were obtained at both baseline and follow-up during 2-h 75-g OGTTs. Baseline analysis included a total of 350 women (216 IBF vs 134 IFF/Mixed) whose stored fasting plasma samples were collected and were subjected to targeted metabolomics and lipidomics profiling. Follow-up and longitudinal analyses included 303 of the 350 women (188 IBF vs 115 IFF/Mixed) whose fasting plasma samples were subject to targeted metabolomics profiling. Targeted metabolomics allowed the detection of 188 analytes and targeted lipidomics allowed detection of 1008 lipid species based on liquid chromatography–mass spectrometry (LC-MS) technique. The generated dataset was then subjected to data pre-processing and bioinformatic analysis
Fig. 1 Overview of the study of women, infant feeding, and type 2 diabetes (SWIFT) cohort and study design. The SWIFT cohort is a prospective longitudinal research cohort of 1035 women with recent GDM enrolled at 6–9 weeks postpartum (baseline) from 2008 to 2011. There were 1010 out of 1035 women who were free of diabetes confirmed by a 2-h 75-g OGTT at baseline. Women were followed up annually via 2-h 75-g OGTT up to 2 years postpartum (n = 959 women), and their electronic medical records (EHR) were utilized to obtain additional clinical diagnoses of diabetes from baseline to 8 years post-baseline (till January 16, 2019). Fasting plasma samples were obtained at both baseline and follow-up during 2-h 75-g OGTTs. Baseline analysis included a total of 350 women (216 IBF vs 134 IFF/Mixed) whose stored fasting plasma samples were collected and were subjected to targeted metabolomics and lipidomics profiling. Follow-up and longitudinal analyses included 303 of the 350 women (188 IBF vs 115 IFF/Mixed) whose fasting plasma samples were subject to targeted metabolomics profiling. Targeted metabolomics allowed the detection of 188 analytes and targeted lipidomics allowed detection of 1008 lipid species based on liquid chromatography–mass spectrometry (LC-MS) technique. The generated dataset was then subjected to data pre-processing and bioinformatic analysisCC BY · PubMed Central
Fig. 2 Metabolites associated with intensive lactation at baseline and follow-up. A Number of differentially expressed metabolites associated with lactation intensity in each class. Red indicates significantly upregulated metabolites whereas blue indicates significantly downregulated, and grey denotes no significant change. Significance was indicated by FDR < 0.05. B Bubble plot showing significantly differentially expressed metabolites (FDR < 0.002) associated with lactation intensity in each class at baseline. Red points indicate upregulation and blue points denote downregulation. The value of -log10 FDR of each metabolite is shown in the bubble. C Comparison of the log2 FC of the significantly differentially expressed metabolites identified at baseline and follow-up
Fig. 2 Metabolites associated with intensive lactation at baseline and follow-up. A Number of differentially expressed metabolites associated with lactation intensity in each class. Red indicates significantly upregulated metabolites whereas blue indicates significantly downregulated, and grey denotes no significant change. Significance was indicated by FDR < 0.05. B Bubble plot showing significantly differentially expressed metabolites (FDR < 0.002) associated with lactation intensity in each class at baseline. Red points indicate upregulation and blue points denote downregulation. The value of -log10 FDR of each metabolite is shown in the bubble. C Comparison of the log2 FC of the significantly differentially expressed metabolites identified at baseline and follow-upCC BY · PubMed Central
Fig. 3 Lipid species associated with intensive lactation at baseline. A Volcano plot showing log2 FC against -log10 FDR of 818 lipid species measured at baseline in the IBF group compared to the IFF/Mixed group. Blue points indicate significantly differentially expressed neutral lipids, red denotes phospholipids, and yellow indicates sphingolipids. Grey points indicate no significant change. Table shows the sum number of differentially/non-differentially expressed lipid species in three lipid groups. Significance was indicated by FDR < 0.05. B Number of lactation intensity-associated metabolites in 15 lipid classes. Red indicates upregulated metabolites whereas blue indicates downregulated, and grey denotes no significant change. Significance was indicated by FDR < 0.05. C Bubble plot showing the top 150 (organized by FDR value) most significantly differentially expressed lipid species associated with lactation intensity. Red points indicate upregulation and blue points denote downregulation
Fig. 3 Lipid species associated with intensive lactation at baseline. A Volcano plot showing log2 FC against -log10 FDR of 818 lipid species measured at baseline in the IBF group compared to the IFF/Mixed group. Blue points indicate significantly differentially expressed neutral lipids, red denotes phospholipids, and yellow indicates sphingolipids. Grey points indicate no significant change. Table shows the sum number of differentially/non-differentially expressed lipid species in three lipid groups. Significance was indicated by FDR < 0.05. B Number of lactation intensity-associated metabolites in 15 lipid classes. Red indicates upregulated metabolites whereas blue indicates downregulated, and grey denotes no significant change. Significance was indicated by FDR < 0.05. C Bubble plot showing the top 150 (organized by FDR value) most significantly differentially expressed lipid species associated with lactation intensity. Red points indicate upregulation and blue points denote downregulationCC BY · PubMed Central
Fig. 4 Characterization of lipid structure associated with intensive lactation at baseline. A Association between lactation intensity groups and lipid structure including the number of carbon atoms and double bonds in each lipid species from 15 lipid classes. Log2 FC of each lipid species are indicated with dots, with color of dots indicating log2 FC value, and dot size denoting significance by FDR value. B Association between lactation intensity and fatty acid composition in 15 lipid classes. Red and blue color indicate log2 FC with significance (FDR < 0.05), whereas white color denotes no significant difference, and grey color indicates not detected
Fig. 4 Characterization of lipid structure associated with intensive lactation at baseline. A Association between lactation intensity groups and lipid structure including the number of carbon atoms and double bonds in each lipid species from 15 lipid classes. Log2 FC of each lipid species are indicated with dots, with color of dots indicating log2 FC value, and dot size denoting significance by FDR value. B Association between lactation intensity and fatty acid composition in 15 lipid classes. Red and blue color indicate log2 FC with significance (FDR < 0.05), whereas white color denotes no significant difference, and grey color indicates not detectedCC BY · PubMed Central
Fig. 5 Metabolic pathways associated with intensive lactation at baseline. A Significantly regulated metabolic pathways (p < 0.05) associated with intensive lactation at baseline analyzed by Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Blue indicates downregulated pathway whereas red indicates upregulated pathway. B Integrated metabolic pathway of synthesis of 15 lipid classes from neutral lipids, phospholipids, and sphingolipids. Red indicates upregulation, and blue denotes downregulation with p value indicated
Fig. 5 Metabolic pathways associated with intensive lactation at baseline. A Significantly regulated metabolic pathways (p < 0.05) associated with intensive lactation at baseline analyzed by Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Blue indicates downregulated pathway whereas red indicates upregulated pathway. B Integrated metabolic pathway of synthesis of 15 lipid classes from neutral lipids, phospholipids, and sphingolipids. Red indicates upregulation, and blue denotes downregulation with p value indicatedCC BY · PubMed Central
Fig. 6 Regulatory network analysis of master regulons and genes that participate in metabolism of lipids associated with intensive lactation. A Flow chart of the identification of co-expressed genes and the master regulons from altered lipids by using MetaBridge and iRegulon. B iRegulon analysis depicting the regulatory network between the master regulons associated with lipid metabolism and their downstream target genes
Fig. 6 Regulatory network analysis of master regulons and genes that participate in metabolism of lipids associated with intensive lactation. A Flow chart of the identification of co-expressed genes and the master regulons from altered lipids by using MetaBridge and iRegulon. B iRegulon analysis depicting the regulatory network between the master regulons associated with lipid metabolism and their downstream target genesCC BY · PubMed Central
Fig. 7 The effect of postpartum lactation on lipid profiling in future T2D and no T2D women at baseline. A The number of IBF and IFF/Mixed women in the future T2D subgroup and no T2D subgroup. B The number of significantly differentially expressed lipid species in 15 lipid classes between IBF and IFF/Mixed in the no T2D subgroup. C Differentially expressed lipids between IBF and IFF/Mixed in the T2D and no T2D subgroups. Log2 FC values of all differentially expressed lipids with FDR < 0.001 between IBF and IFF/Mixed in the no T2D subgroup are shown in green color. The log2 FC values of these lipid species between IBF and IFF/Mixed in future T2D subgroup are shown in red color. Solid dots represent significance, empty dots indicate non-significance. D The number of significantly differentially expressed lipid species in 15 lipid classes between IBF and IFF/Mixed in the future T2D subgroup
Fig. 7 The effect of postpartum lactation on lipid profiling in future T2D and no T2D women at baseline. A The number of IBF and IFF/Mixed women in the future T2D subgroup and no T2D subgroup. B The number of significantly differentially expressed lipid species in 15 lipid classes between IBF and IFF/Mixed in the no T2D subgroup. C Differentially expressed lipids between IBF and IFF/Mixed in the T2D and no T2D subgroups. Log2 FC values of all differentially expressed lipids with FDR < 0.001 between IBF and IFF/Mixed in the no T2D subgroup are shown in green color. The log2 FC values of these lipid species between IBF and IFF/Mixed in future T2D subgroup are shown in red color. Solid dots represent significance, empty dots indicate non-significance. D The number of significantly differentially expressed lipid species in 15 lipid classes between IBF and IFF/Mixed in the future T2D subgroupCC BY · PubMed Central
Fig. 8 Metabolic signature to predict future T2D in IBF women at early postpartum. A Variable selection using random forest identified a set of 10 analytes with high predictive power. B ROC of the predictive models generated by 10-analyte signature and traditional clinical variables (fasting glucose and 2-h glucose) in the testing set. C AUC and 95% CI of the ROC curve. D Box plots showing the distribution of the performance of the metabolic signature and traditional clinical parameters (fasting glucose and 2-h plasma glucose) under 100 times’ repeat
Fig. 8 Metabolic signature to predict future T2D in IBF women at early postpartum. A Variable selection using random forest identified a set of 10 analytes with high predictive power. B ROC of the predictive models generated by 10-analyte signature and traditional clinical variables (fasting glucose and 2-h glucose) in the testing set. C AUC and 95% CI of the ROC curve. D Box plots showing the distribution of the performance of the metabolic signature and traditional clinical parameters (fasting glucose and 2-h plasma glucose) under 100 times’ repeatCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Cited by

See all 34

Metadata

Authors
Zhang, Z., Lai, M., Piro, A. L., Alexeeff, S. E., Allalou, A., Röst, H. L., Dai, F. F., Wheeler, M. B., & Gunderson, E. P.
Affiliations
  • University of Toronto (CA)
  • Kaiser Permanente (US)
Corresponding author
  • Dai, Feihan F.
  • Wheeler, Michael B.
  • Gunderson, Erica P.
Venue
BMC Medicine
Published
2021-10-08
Volume
19
Issue
1
Pages
241-241
ISSN
1741-7015 (ISSN-L)
OpenAlex
W3201948151
Cited by
34
References
83
Citations by year
2026: 6 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 1
FWCI
3.78
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Canadian Institutes of Health Research (FRN 143219)
  • The National Institute of Child Health and Human Development (R01HD050625)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK118409)
  • China Scholarship Council
  • Banting and Best Diabetes Centre, University of Toronto
Topics
  • Health Sciences › Medicine › Epidemiology › Breastfeeding Practices and Influences
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
gestational diabetes mellitus, type 2 diabetes risk, glycerolipids, phospholipids, sphingolipids, lipogenesis, metabolic signatures, metabolite profiling, bottle feeding, mixed feeding, type 2 diabetes prediction
MeSH terms
Blood Glucose, Breast Feeding, Diabetes Mellitus, Type 2, Female, Humans, Lactation, Lipids, Pregnancy, Prospective Studies, Diabetes, Gestational, Postpartum Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intensive lactation among women with recent gestational diabetes significantly alters the early postpartum circulating lipid profile: the SWIFT study. https://app.cochat.ai/papers/10.1186/s12916-021-02095-1
The paper
Zhang, Z., Lai, M., Piro, A. L., Alexeeff, S. E., Allalou, A., Röst, H. L., Dai, F. F., Wheeler, M. B., & Gunderson, E. P. (2021). Intensive lactation among women with recent gestational diabetes significantly alters the early postpartum circulating lipid profile: the SWIFT study. BMC Medicine. https://doi.org/10.1186/s12916-021-02095-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.